AXOL BIOSCIENCE LTD

Active Cambridge

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
A

AXOL BIOSCIENCE LTD

Research and experimental development on biotechnology

Founded 21 Dec 2012 Active Cambridge, England 0 employees website.com
Research and experimental development on biotechnology

Previous Company Names

TAYVIN 478 LIMITED 21 Dec 2012 — 24 Jan 2013
Accounts Submitted 11 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 8 Aug 2025 Next due 7 Aug 2026 2 months remaining
Net assets £597K £4K 2023 year on year
Total assets £622K £80K 2023 year on year
Total Liabilities £25K £76K 2023 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Meditrina Building Babraham Babraham Research Campus Babraham Cambridge CB22 3AT England

Website

www.example.com

Full company profile for AXOL BIOSCIENCE LTD (08340031), an active company based in Cambridge, England. Incorporated 21 Dec 2012. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Balance Sheet & P&L (2014–2023)

Cash in Bank

£36.69k

Decreased by £127.49k (-78%)

Net Assets

£597.32k

Decreased by £3.94k (-1%)

Total Liabilities

£24.95k

Decreased by £75.84k (-75%)

Turnover

N/A

Employees

N/A

Debt Ratio

4%

Decreased by 10 (-71%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 10,000 Shares £1k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 May 202010,000£1k£0.1

Officers

Officers

1 active 2 resigned
Status
Harry Thomas StratfordDirectorBritishScotland5516 Mar 2021Active

Shareholders

Shareholders (1)

Censo Biotechnologies Ltd
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 16 Mar 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Yichen Shi

Ceased 16 Mar 2021

Ceased

Group Structure

Group Structure

AXOL BIOSCIENCE LTD Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
12 Jan 2026ResolutionResolutions
12 Jan 2026IncorporationMemorandum Articles
31 Dec 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
11 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
8 Aug 2025Confirmation StatementConfirmation statement made on 24 Jul 2025 with no updates
12 Jan 2026 Resolution

Resolutions

12 Jan 2026 Incorporation

Memorandum Articles

31 Dec 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

11 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

8 Aug 2025 Confirmation Statement

Confirmation statement made on 24 Jul 2025 with no updates

Recent Activity

Latest Activity

Resolutions

4 months ago on 12 Jan 2026

Memorandum Articles

4 months ago on 12 Jan 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

5 months ago on 31 Dec 2025

Annual accounts made up to 31 Dec 2024

8 months ago on 11 Sept 2025

Confirmation statement made on 24 Jul 2025 with no updates

10 months ago on 8 Aug 2025